“Sudemycin E influences alternative splicing and changes chromatin modifications.” Convertini P, Shen M, Potter PM, Palacios G, Lagisetti C, de la Grange P, Horbinski C, Fondufe-Mittendorf YN, Webb TR, Stamm S., Nucleic Acids Res. 2014 Mar 11. Pubmed
“A Gene Expression and Pre-mRNA Splicing Signature That Marks the Adenoma-Adenocarcinoma Progression in Colorectal Cancer” Pesson M, Volant A, Uguen A, Trillet K, De La Grange P, Aubry M, Daoulas M, Robaszkiewicz M, Le Gac G, Morel A, Simon B, Corcos L., PLoS One. 2014 Feb 6. Pubmed
“A dedicated microarray for in-depth analysis of pre-mRNA splicing events: application to the study of genes involved in the response to targeted anticancer therapies” Pesson M, Eymin B, De La Grange P, Simon B, Corcos L., Mol. Cancer, 2014 Jan. Pubmed
“Valproic Acid Causes Proteasomal Degradation of DICER and Influences miRNA Expression” Zhang Z, Convertini P, Shen M, Xu X, Lemoine F, de la Grange P, Andres DA, Stamm S, PLoS One. 2013 Dec. Pubmed
The publication “BCL-2 inhibition with ABT-737 prolongs survival in an NRAS/BCL-2 mouse model of AML by targeting primitive LSK and progenitor cells” is on the cover of Blood Journal.
“CXXC5 (Retinoid-Inducible Nuclear Factor, RINF) is a Potential Therapeutic Target in High-Risk Human Acute Myeloid Leukemia.” Astori A, Fredly H, Aloysius TA, Bullinger L, Mas VM, de la Grange P, Delhommeau F, Hagen KM, Récher C, Dusanter-Fourt I, Knappskog S, Lillehaug JR, Pendino F, Bruserud O, Oncotarget, 2013 Aug. Pubmed
“BCL-2 inhibition with ABT-737 prolongs survival in an NRAS/BCL-2 mouse model of AML by targeting primitive LSK and progenitor cells.” Beurlet S, Omidvar N, Gorombei P, Krief P, Le Pogam C, Setterblad N, de la Grange P, Leboeuf C, Janin A, Noguera ME, Hervatin F, Sarda-Mantel L, Konopleva M, Andreeff Read more…
“SF3B1 mutations are associated with alternative splicing in uveal melanoma” Furney SJ, Pedersen M, Gentien D, Dumont AG, Rapinat A, Desjardins L, Turajlic S, Piperno-Neumann S, de la Grange P, Roman-Roman S, Stern MH, Marais R. Cancer Discov. 2013 Jul Pubmed
“Molecular characterization of a patient presumed to have prader-willi syndrome” Falaleeva M, Sulsona CR, Zielke HR, Currey KM, de la Grange P, Aslanzadeh V, Driscoll DJ, Stamm S. Clin Med Insights Case Rep. 2013 May Pubmed
“Human Induced Pluripotent Stem Cells As a Tool to Model a Form of Leber Congenital Amaurosis” Lustremant C, Habeler W, Plancheron A, Goureau O, Grenot L, de la Grange P, Audo I, Nandrot EF, Monville C., Cell Reprogram. 2013 May 10 Pubmed